Cigna
CI
Market cap $84.8B

317.40 USD

+2.03

0.64%

At close Jun 13, 4:00 PM EDT

After hours

317.40

+0.00

0.00%

1 day

0.64%

5 days

2.11%

1 month

5.14%

3 months

1.73%

6 months

12.61%

Year to date

15.63%

1 year

-5.01%

5 years

69.61%

10 years

106.87%

About: Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.

Employees: 73,500

Healthcare Healthcare Plans

0

Funds holding %

of 7,296 funds

0

Analysts bullish %

of 10 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

73% more funds holding in top 10

Funds holding in top 10: 22 [Q4 2024] → 38 (+16) [Q1 2025]

60% more call options, than puts

Call options by funds: $1.41B | Put options by funds: $879M

48% more first-time investments, than exits

New positions opened: 193 | Existing positions closed: 130

16% more capital invested

Capital invested by funds: $67.1B [Q4 2024] → $77.7B (+$10.6B) [Q1 2025]

2% more funds holding

Funds holding: 1,617 [Q4 2024] → 1,654 (+37) [Q1 2025]

0.29% less ownership

Funds ownership: 87.36% [Q4 2024] → 87.07% (-0.29%) [Q1 2025]

8% less repeat investments, than reductions

Existing positions increased: 570 | Existing positions reduced: 622

See Fund Rankings

Research analyst outlook

10 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$362

14%

upside

Avg. target

$381

20%

upside

High target

$405

28%

upside

10 analyst ratings

10 positive

100%

0 neutral

0%

0 negative

0%

RBC Capital Ben Hendrix	17%upside $371	Outperform Reiterated	3 Jun 2025
Barclays Andrew Mok	21%upside $385	Overweight Maintained	2 Jun 2025
Guggenheim Jason Cassorla	22%upside $388	Buy Reiterated	23 May 2025
Truist Securities David Macdonald	28%upside $405	Buy Maintained	12 May 2025
Piper Sandler Jessica Tassan	18%upside $374	Overweight Maintained	5 May 2025

See Analyst Rankings

Financial journalist opinion

Based on 13 articles about CI published over the past 30 days

Wake Up Wall Street - 2 Massively Mispriced Dividend Gems

I believe the odds favor long-term market gains. Analysts' optimism supports my view that overlooked areas offer the best opportunities now. That's why I'm focusing on two dividend stocks with rising income and resilience, one in energy, and one in healthcare, built for long-term success. Forget the headlines. Quality, time, and patience build wealth. I'm doubling down on proven businesses, no matter what short-term noise brings.

Wake Up Wall Street - 2 Massively Mispriced Dividend Gems

Cigna Healthcare Unveils Industry-Leading AI-Powered Digital Tools for a Simple and Reliable Customer Experience

New features blend innovation, responsible AI, and human interactions to better support customers in their health care journeys As new data show 4 out of 5 U.S. adults don't feel confident in their knowledge of health insurance benefits, new digital tools use clear, conversational language to boost understanding and help customers get more out of their coverage BLOOMFIELD, Conn. , June 12, 2025 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), is introducing a series of new digital features to improve the customer experience during common health insurance interactions, such as checking benefits coverage, estimating costs and finding care.

Cigna Healthcare Unveils Industry-Leading AI-Powered Digital Tools for a Simple and Reliable Customer Experience

The Cigna Group Health Equity Impact Fund Opens 2025 Grants

The Fund will distribute another $3 million to nonprofits to improve health outcomes BLOOMFIELD, Conn. , June 4, 2025 /PRNewswire/ -- The Cigna Group Foundation today announced the second year of grants from its Health Equity Impact Fund.

The Cigna Group Health Equity Impact Fund Opens 2025 Grants

The Cigna Group Announces Appointment of Michael J. Hennigan to Board of Directors

BLOOMFIELD, Conn. , June 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Michael J.

The Cigna Group Announces Appointment of Michael J. Hennigan to Board of Directors

Zacks Investment Research

Here's Why You Should Hold Cigna Stock in Your Portfolio for Now

CI gains 14.7% YTD as Evernorth and Cigna Healthcare drive growth, but rising expenses and debt pose challenges.

Here's Why You Should Hold Cigna Stock in Your Portfolio for Now

Zacks Investment Research

CVS or Cigna: Which Diversified Healthcare Stock Should You Own Now?

CVS rallies on turnaround momentum and EPS growth, while CI is a defensive play with stable returns and a focused healthcare strategy.

CVS or Cigna: Which Diversified Healthcare Stock Should You Own Now?

Zacks Investment Research

CI's Unit Unveils Offering to Expand Access to GLP-1 Medications

Cigna's Evernorth business caps GLP-1 drug copays at $200 or less, aiming to boost affordability for patients and cut costs for health plan sponsors.

CI's Unit Unveils Offering to Expand Access to GLP-1 Medications

Cigna Adds Kerecis Intact Fish-Skin Grafts to Coverage Policy

ARLINGTON, Va. & REYKJAVIK, Iceland--(BUSINESS WIRE)-- #kerecis--Cigna Insurance Company now includes Kerecis products in its medical coverage policy for the treatment of diabetic foot ulcers.

Cigna Adds Kerecis Intact Fish-Skin Grafts to Coverage Policy

Cigna to offer $200 Wegovy, Zepbound weight-loss benefit

Cigna said on Wednesday it was launching an add-on to pharmacy benefit management plans in which patients could pay no more than $200 a month out-of-pocket for weight-loss drugs Wegovy and Zepbound.

Cigna to offer $200 Wegovy, Zepbound weight-loss benefit

Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs

Cigna's Evernorth unit said a new coverage deal with Eli Lilly and Novo Nordisk will bring lower copays for insured patients The company hopes the new discount, which caps monthly out-of-pocket costs at $200 for Wegovy and Zepbound, will convince more employers to offer coverage of the drugs.

Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs

See News Rankings

Charts implemented using Lightweight Charts™